https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1524214/full
Frontiers | Comparative effectiveness and safety of tofacitinib vs. adalimumab in patients with...
ObjectivesTo provide the latest systematic review and meta-analysis comparing the effectiveness and safety of tofacitinib and adalimumab in rheumatoid arthri...
comparative effectiveness
https://www.cochrane.org/zh-hans/evidence/CD012381_oral-janus-kinase-inhibitors-tofacitinib-maintenance-remission-ulcerative-colitis
Oral Janus kinase inhibitors (tofacitinib) for maintenance of remission in ulcerative colitis |...
janus kinasefor maintenance
https://www.seisakukoushien2025.com/
Tofacitinib (CP-690550) HOME | 政策甲子園
tofacitinibcp
https://www.biospace.com/press-releases/cage-bio-announces-phase-2b-trial-for-cgb-500-1-tofacitinib-a-breakthrough-topical-jak-inhibitor-for-moderate-to-severe-atopic-dermatitis
CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK...
https://www.indiamart.com/narix-pharmaceuticals-private-limited/anti-cancer-drugs.html
Anti Cancer Drugs - Tofacitinib 5 Mg Tablets Trader - Wholesaler / Distributor from Mumbai
Trader - Wholesaler / Distributor of Anti Cancer Drugs - Tofacitinib 5 Mg Tablets, Bevacizumab 100 Mg, 50mg Stano Stanozolol Injection and Fluorouracil...
anti cancer drugs5 mg
https://www.cochrane.org/de/evidence/CD012437_biologics-or-tofacitinib-alone-people-rheumatoid-arthritis-who-had-not-improved-traditional-disease
Biologics or tofacitinib alone for people with rheumatoid arthritis who had not improved with...
https://en.wikipedia.org/wiki/Tofacitinib
Tofacitinib - Wikipedia
tofacitinibwikipedia
https://grizz-pharmaceutical.com/
GRIZZ PHARMACEUTICAL - 3rd Party Manufacturing, Tofacitinib Manufacturer, Tofacitinib Manufacturer,...
tofacitinib manufacturer 3rd party manufacturing
3rd party manufacturinggrizzpharmaceuticaltofacitinibmanufacturer
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1515602/full
Frontiers | Case report: Exploring efficacy of tofacitinib in modulating interferon response in...
A case report highlights the challenges faced in managing a 66-year-old Chinese woman diagnosed with anti-MDA5 antibody-positive dermatomyositis (MDA5-DM) co...
case reportfrontiersexploringefficacy
https://www.thebusinessresearchcompany.com/report/tofacitinib-global-market-report
Tofacitinib Market Size and Statistics 2026 to 2035
Tofacitinib market to reach $6.53 billion by 2030 at 14.0% CAGR, driven by increasing number of patients with inflammatory bowel disease.
market sizetofacitinibstatistics20262035
https://www.arthritis.org/drug-guide/dmards/tofacitinib
Tofacitinib
Oct 17, 2025 - Drug Class: DMARDs Brand Names: Xeljanz, Xeljanz XR
tofacitinib